![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/48 | |
A61P 43/00 |
(11) | Number of the document | 1713497 |
(13) | Kind of document | T |
(96) | European patent application number | 05707943.6 |
Date of filing the European patent application | 2005-02-04 | |
(97) | Date of publication of the European application | 2006-10-25 |
(45) | Date of publication and mention of the grant of the patent | 2016-04-13 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2005/050486 |
Date | 2005-02-04 |
(87) | Number | WO 2005/074974 |
Date | 2005-08-18 |
(30) | Number | Date | Country code |
200400178 | 2004-02-05 | DK | |
200400339 | 2004-03-01 | DK | |
200400341 | 2004-03-01 | DK | |
200401240 | 2004-08-16 | DK | |
200401239 | 2004-08-16 | DK | |
200401552 | 2004-10-08 | DK | |
200401553 | 2004-10-08 | DK |
(72) |
AXELSEN, Mads, DK
ERHARDTSEN, Elisabeth, DK
SKOLNICK, Brett, E., US
|
(73) |
Novo Nordisk Health Care AG,
Thurgauerstrasse 36/38 8050 Zürich,
CH
|
(54) | USE OF FACTOR VIIA FOR TREATING LATE COMPLICATIONS OF TRAUMA |
USE OF FACTOR VIIA FOR TREATING LATE COMPLICATIONS OF TRAUMA |